timolol has been researched along with Cardiovascular Diseases in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 3 (12.50) | 24.3611 |
| 2020's | 2 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dahle, SE; Gallegos, A; Isseroff, RR; Kaur, R; Schaefer, S; Tchanque-Fossuo, C; West, K; Yang, H; Yoon, DJ | 1 |
| Chen, YW; Hsu, CW; Huang, KY; Lin, CH; Lin, PY; Matsuoka, YJ; Stubbs, B; Su, KP; Tseng, PT; Tu, YK; Wu, YC | 1 |
| Samuelson, TW | 1 |
| Backman, JT; Kautiainen, H; Mäenpää, J; Neuvonen, M; Neuvonen, PJ; Niemi, M; Volotinen-Maja, M | 1 |
| de Jong, PT; Hofman, A; Jansonius, NM; Müskens, RP; Stricker, BH; Witteman, JC; Wolfs, RC | 1 |
| Covert, DW; Lau, EC; Schmier, JK | 1 |
| Lama, PJ | 1 |
| Kifley, A; Lee, AJ; Mitchell, P; Wang, JJ | 1 |
| Meyer, NI | 1 |
| Borer, JS; Camm, AJ; Danchin, N; Ferrari, R; Fox, K; Lopez Sendon, JL; Steg, PG; Tardif, JC; Tavazzi, L; Tendera, M | 1 |
| Franks, W; Sharkawi, E | 1 |
| Levine, L | 1 |
| McGoon, MD; Vlietstra, RE | 1 |
| Adler, AG; Martin, JH; McElwain, GE; Merli, GJ | 1 |
| Fraunfelder, FT; Van Buskirk, EM | 1 |
| Van Buskirk, EM | 1 |
| Poryzees, E; Spaeth, GL; Wilson, RP | 1 |
| Iga, T; Ito, K; Ohtani, H; Sawada, Y; Takayanagi, R; Tsuchiya, K; Yamada, Y | 1 |
| Hetherington, J; Hoskins, HD; McMahon, CD; Shaffer, RN | 1 |
| Domingo Regany, E; Massagué Camins, C; Quilis Salcedo, M | 1 |
| Vogel, R | 1 |
| Nelson, WP | 1 |
| Kershner, RM; Munroe, WP; Rindone, JP | 1 |
| Netter, P; Sirbat, D; Trechot, P | 1 |
4 review(s) available for timolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Repurposing Ophthalmologic Timolol for Dermatologic Use: Caveats and Historical Review of Adverse Events.
Topics: Absorption, Physiological; Administration, Cutaneous; Adrenergic beta-Antagonists; Cardiovascular Diseases; Drug Repositioning; Hemangioma; History, 20th Century; Humans; Ophthalmic Solutions; Respiration Disorders; Skin; Timolol | 2021 |
Do beta-adrenergic blocking agents increase asthma exacerbation? A network meta-analysis of randomized controlled trials.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Cardiovascular Diseases; Celiprolol; Disease Progression; Female; Humans; Incidence; Infusions, Intravenous; Male; Practolol; Propranolol; Randomized Controlled Trials as Topic; Risk; Sotalol; Status Asthmaticus; Timolol | 2021 |
Resting heart rate in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Calcium Channel Blockers; Carbazoles; Cardiac Output, Low; Cardiovascular Diseases; Carvedilol; Coronary Artery Disease; Coronary Disease; Exercise Test; Heart Rate; Humans; Metoprolol; Multivariate Analysis; Myocardial Infarction; Myocardial Ischemia; Prognosis; Propanolamines; Risk Assessment; Risk Factors; Timolol; Ventricular Dysfunction, Left | 2007 |
Systemic side effects associated with the ophthalmic administration of timolol.
Topics: Absorption; Aged; Cardiovascular Diseases; Central Nervous System Diseases; Female; Humans; Kinetics; Lung Diseases; Ophthalmic Solutions; Skin Diseases; Timolol | 1985 |
20 other study(ies) available for timolol and Cardiovascular Diseases
| Article | Year |
|---|---|
Coincident cataract and glaucoma surgery in an anticoagulated patient: January consultation #1.
Topics: Aged; Anticoagulants; Antihypertensive Agents; Bimatoprost; Cardiovascular Diseases; Cataract; Cataract Extraction; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Timolol; Trabeculectomy; Visual Acuity; Visual Field Tests; Visual Fields; Warfarin | 2018 |
Paroxetine markedly increases plasma concentrations of ophthalmic timolol; CYP2D6 inhibitors may increase the risk of cardiovascular adverse effects of 0.5% timolol eye drops.
Topics: Adult; Area Under Curve; Cardiovascular Diseases; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Drug Interactions; Eye; Heart Rate; Humans; Male; Ophthalmic Solutions; Paroxetine; Risk; Timolol; Young Adult | 2014 |
Topical beta-blockers and mortality.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Cardiovascular Diseases; Cause of Death; Cerebrovascular Disorders; Cholesterol; Female; Glaucoma; Humans; Male; Proportional Hazards Models; Prospective Studies; Timolol | 2008 |
Medical service encounters and payments associated with topical adjunctive therapy use of timolol for glaucoma.
Topics: Administration, Ophthalmic; Adrenergic beta-Antagonists; Age Factors; Aged; Cardiovascular Diseases; Databases, Factual; Female; Glaucoma, Open-Angle; Health Care Costs; Hospitalization; Humans; Male; Middle Aged; Respiratory Tract Diseases; Retrospective Studies; Time Factors; Timolol | 2012 |
Topical beta-adrenergic blockers and glaucoma: a heart-stopping association?
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; New South Wales; Risk Factors; Timolol | 2006 |
Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Female; Glaucoma, Open-Angle; Humans; Longitudinal Studies; Male; Middle Aged; New South Wales; Optic Disk; Optic Nerve Diseases; Proportional Hazards Models; Registries; Risk Factors; Survival Rate; Timolol; Vision Disorders; Visual Fields | 2006 |
Open-angle glaucoma and cardiovascular mortality.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Cardiovascular Diseases; Cause of Death; Glaucoma, Open-Angle; Humans; New South Wales; Optic Disk; Optic Nerve Diseases; Risk Factors; Survival Rate; Timolol | 2007 |
Glaucoma and mortality.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Cardiovascular Diseases; Cause of Death; Glaucoma, Open-Angle; Humans; New South Wales; Optic Disk; Optic Nerve Diseases; Proportional Hazards Models; Risk Factors; Survival Rate; Timolol; Vision Disorders; Visual Fields | 2008 |
Clinical implications of reported timolol-induced side effects.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Electrooculography; Gastrointestinal Diseases; Glaucoma, Open-Angle; Humans; Lung Diseases; Mental Disorders; Pain; Propanolamines; Prospective Studies; Timolol; Vision Disorders | 1982 |
Beta-adrenergic blockers. Choosing among them.
Topics: Adrenergic beta-Antagonists; Atenolol; Cardiovascular Diseases; Humans; Kinetics; Metoprolol; Nadolol; Pindolol; Propanolamines; Propranolol; Timolol | 1984 |
Systemic effects of eye drops.
Topics: Cardiovascular Diseases; Central Nervous System Diseases; Echothiophate Iodide; Humans; Ophthalmic Solutions; Phenylephrine; Timolol | 1982 |
Timolol and glaucoma.
Topics: Aged; Cardiovascular Diseases; Cerebrovascular Disorders; Humans; Propanolamines; Timolol | 1981 |
Adverse reactions from timolol administration.
Topics: Cardiovascular Diseases; Central Nervous System Diseases; Corneal Diseases; Depression; Eye Diseases; Gastrointestinal Diseases; Glaucoma; Humans; Lung Diseases; Propanolamines; Skin Diseases; Timolol | 1980 |
The place of timolol in the practice of ophthalmology.
Topics: Aged; Bradycardia; Cardiovascular Diseases; Central Nervous System Diseases; Eye Diseases; Female; Glaucoma; Humans; Hypertension; Male; Mental Disorders; Propanolamines; Timolol | 1980 |
Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Cardiovascular Diseases; Carteolol; Exercise; Forced Expiratory Volume; Heart; Heart Rate; Humans; Lung; Ophthalmic Solutions; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Respiration Disorders; Retrospective Studies; Timolol | 2001 |
Adverse effects experienced by patients taking timolol.
Topics: Aged; Asthma; Cardiovascular Diseases; Central Nervous System Diseases; Child; Eye Diseases; Female; Follow-Up Studies; Humans; Intraocular Pressure; Male; Middle Aged; Propanolamines; Respiratory Tract Diseases; Timolol; Vision Disorders | 1979 |
[Timolol: adverse cardiorespiratory effects].
Topics: Aged; Cardiovascular Diseases; Chronic Disease; Dyspnea; Female; Glaucoma, Open-Angle; Humans; Timolol | 1989 |
Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985.
Topics: Cardiovascular Diseases; Humans; Ophthalmic Solutions; Respiration Disorders; Timolol | 1987 |
Adverse respiratory and cardiovascular events attributed to timolol ophthalmic solution, 1978-1985.
Topics: Cardiovascular Diseases; Humans; Ophthalmic Solutions; Respiration Disorders; Timolol | 1987 |
[Systemic effects of ophthalmic solutions].
Topics: Adrenal Cortex Hormones; Animals; Anti-Bacterial Agents; Cardiovascular Diseases; Diffusion; Eye Diseases; Hematologic Diseases; Mydriatics; Nervous System Diseases; Ophthalmic Solutions; Parasympatholytics; Parasympathomimetics; Sulfonamides; Sympathomimetics; Timolol | 1985 |